Annual Accounts Receivable
$613.73 M
-$128.06 M-17.26%
31 December 2023
Summary:
Amneal Pharmaceuticals annual accounts receivable is currently $613.73 million, with the most recent change of -$128.06 million (-17.26%) on 31 December 2023. During the last 3 years, it has fallen by -$25.16 million (-3.94%). AMRX annual accounts receivable is now -17.26% below its all-time high of $741.79 million, reached on 31 December 2022.AMRX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$748.05 M
-$21.82 M-2.83%
30 September 2024
Summary:
Amneal Pharmaceuticals quarterly accounts receivable is currently $748.05 million, with the most recent change of -$21.82 million (-2.83%) on 30 September 2024. Over the past year, it has increased by +$57.11 million (+8.27%). AMRX quarterly accounts receivable is now -2.83% below its all-time high of $769.87 million, reached on 30 June 2024.AMRX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.3% | +8.3% |
| 3 y3 years | -3.9% | +19.1% |
| 5 y5 years | +27.5% | +44.4% |
AMRX Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -17.3% | at low | -2.8% | +39.0% |
| 5 y | 5 years | -17.3% | +27.5% | -2.8% | +44.4% |
| alltime | all time | -17.3% | +74.7% | -2.8% | +112.9% |
Amneal Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $748.05 M(-2.8%) |
| June 2024 | - | $769.87 M(+15.1%) |
| Mar 2024 | - | $668.96 M(+9.0%) |
| Dec 2023 | $613.73 M(-17.3%) | $613.73 M(-11.2%) |
| Sept 2023 | - | $690.95 M(+2.4%) |
| June 2023 | - | $674.74 M(+23.6%) |
| Mar 2023 | - | $545.76 M(-26.4%) |
| Dec 2022 | $741.79 M(+12.0%) | $741.79 M(+18.0%) |
| Sept 2022 | - | $628.74 M(-8.7%) |
| June 2022 | - | $688.85 M(+28.0%) |
| Mar 2022 | - | $538.31 M(-18.8%) |
| Dec 2021 | $662.58 M | $662.58 M(+5.5%) |
| Sept 2021 | - | $627.95 M(-3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $652.01 M(+22.9%) |
| Mar 2021 | - | $530.60 M(-17.0%) |
| Dec 2020 | $638.89 M(+5.7%) | $638.89 M(-9.6%) |
| Sept 2020 | - | $707.10 M(+21.3%) |
| June 2020 | - | $582.73 M(-19.4%) |
| Mar 2020 | - | $722.68 M(+19.6%) |
| Dec 2019 | $604.39 M(+25.5%) | $604.39 M(+16.7%) |
| Sept 2019 | - | $518.11 M(-18.4%) |
| June 2019 | - | $634.67 M(-0.9%) |
| Mar 2019 | - | $640.21 M(+33.0%) |
| Dec 2018 | $481.50 M(+37.0%) | $481.50 M(-24.9%) |
| Sept 2018 | - | $641.03 M(+2.3%) |
| June 2018 | - | $626.49 M(+78.3%) |
| Dec 2017 | $351.37 M | $351.37 M |
FAQ
- What is Amneal Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual accounts receivable year-on-year change?
- What is Amneal Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Amneal Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of AMRX is $613.73 M
What is the all time high annual accounts receivable for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual accounts receivable is $741.79 M
What is Amneal Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, AMRX annual accounts receivable has changed by -$128.06 M (-17.26%)
What is Amneal Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of AMRX is $748.05 M
What is the all time high quarterly accounts receivable for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly accounts receivable is $769.87 M
What is Amneal Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, AMRX quarterly accounts receivable has changed by +$57.11 M (+8.27%)